Literature DB >> 31010869

Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against Fusarium Species Ocular Isolates.

Michael E Zegans1,2, Robert A Cramer3, Christiaan A Rees1, Ruina Bao1.   

Abstract

The in vitro activities of two antifungal drugs in combination with four nonantifungal ophthalmic agents were evaluated using a broth microdilution method and a collection of eight Fusarium ocular isolates that exhibited resistance to both natamycin (MICs, 14 to 32 μg/ml) and voriconazole (MICs, 4 to >128 μg/ml). Synergistic and indifferent interactions were observed for natamycin and 5-fluorouracil and natamycin with timolol dependent on the Fusarium isolate tested. Isolate-dependent synergistic and indifferent interactions were also observed for natamycin with EDTA and natamycin with dorzolamide. Synergistic or indifferent interactions were observed for voriconazole with timolol and voriconazole with 5-fluorouracil depending on Fusarium isolate. Taken together, these data suggest that commonly used ophthalmic agents enhance the in vitro activity of antifungal drugs against drug-recalcitrant ocular fungal pathogens.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Fusarium; antifungal susceptibility testing; fungal keratitis; ocular

Year:  2019        PMID: 31010869      PMCID: PMC6591621          DOI: 10.1128/AAC.02505-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Authors:  J P Donnelly; B E De Pauw
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

2.  Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.

Authors:  Prajna Lalitha; Brett L Shapiro; Allison R Loh; Annette W Fothergill; N Venkatesh Prajna; M Srinivasan; Catherine E Oldenburg; David A Quigley; Jaya D Chidambaram; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

3.  In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.

Authors:  William L Weinstein; Phillip A Moore; Susan Sanchez; Ursula M Dietrich; Richard E Wooley; Branson W Ritchie
Journal:  Am J Vet Res       Date:  2006-04       Impact factor: 1.156

4.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.

Authors:  Aspasia Katragkou; Matthew McCarthy; Joseph Meletiadis; Vidmantas Petraitis; Patriss W Moradi; Gittel E Strauss; Monique M Fouant; Laura L Kovanda; Ruta Petraitiene; Emmanuel Roilides; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

6.  Propranolol inhibits hyphal development in Candida albicans.

Authors:  Carol A Baker; Kevin Desrosiers; Joseph W Dolan
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

7.  Antimicrobial activity of maleic acid and combinations of cetrimide with chelating agents against Enterococcus faecalis biofilm.

Authors:  Carmen María Ferrer-Luque; María Teresa Arias-Moliz; María Paloma González-Rodríguez; Pilar Baca
Journal:  J Endod       Date:  2010-08-17       Impact factor: 4.171

8.  Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.

Authors:  Arzu Gunes; Ugur Coskun; Cem Boruban; Nazan Gunel; Melih O Babaoglu; Orhan Sencan; Atila Bozkurt; Anders Rane; Moustapha Hassan; Hakan Zengil; Umit Yasar
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-02       Impact factor: 4.080

9.  The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.

Authors:  N Venkatesh Prajna; Tiruvengada Krishnan; Jeena Mascarenhas; Revathi Rajaraman; Lalitha Prajna; Muthiah Srinivasan; Anita Raghavan; Catherine E Oldenburg; Kathryn J Ray; Michael E Zegans; Stephen D McLeod; Travis C Porco; Nisha R Acharya; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

Review 10.  Fungal keratitis.

Authors:  M Srinivasan
Journal:  Curr Opin Ophthalmol       Date:  2004-08       Impact factor: 3.761

View more
  3 in total

Review 1.  Update on the management of fungal keratitis.

Authors:  Xiao-Yuan Sha; Qi Shi; Lian Liu; Jing-Xiang Zhong
Journal:  Int Ophthalmol       Date:  2021-04-30       Impact factor: 2.031

2.  The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex.

Authors:  Yujie Cen; Yingyu Li; Pei Zhang; Ziyuan Liu; Chen Huang; Wei Wang
Journal:  Lasers Med Sci       Date:  2022-01-29       Impact factor: 3.161

3.  CRISPR/Cas9-Mediated Gene Replacement in the Fungal Keratitis Pathogen Fusarium solani var. petroliphilum.

Authors:  Jorge D Lightfoot; Kevin K Fuller
Journal:  Microorganisms       Date:  2019-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.